Companies Dominating the Buprenorphine Landscape
- The Siegfried Group, LLP
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson Matthey Group
- Purdue Pharma LP
- Pharmaforce Inc.
- Hikma Pharmaceuticals PLC
- Bedford Laboratories
- Sun Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Neon Laboratories Ltd.
- Unichem Laboratories
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of buprenorphine is assessed at USD 6.98 billion.
Buprenorphine Market size was valued at USD 6.22 billion in 2024 and is expected to reach USD 35.75 billion by 2037, expanding at around 14.4% CAGR during the forecast period i.e., between 2025-2037.
North America industry is set to account for largest revenue share by 2037, on the back of strong presence of market players and growing percentage of the population suffering from opioid dependency in the region.
The major players in the market are The Siegfried Group, LLP, Johnson Matthey Group, Purdue Pharma LP, Pharmaforce Inc., Hikma Pharmaceuticals PLC, and others.
